CASM / CAS Medical Systems, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

CAS Medical Systems, Inc.
US ˙ NASDAQ
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier45.400.055 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

CAS Medical Systems, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CASM / CAS Medical Systems, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2018-03-19 Acuta Capital Fund, LP 1.088 1,2513 1.088 1,2513 1.361 143 2.6700 1.544 113,44
2018-03-16 Acuta Capital Fund, LP 2.176 1,2500 2.176 1,2500 2.720
2018-03-15 Acuta Capital Fund, LP 9.370 1,1583 9.370 1,1583 10.853
2018-03-09 Acuta Capital Fund, LP 1.180 1,0723 1.180 1,0723 1.265
2018-03-08 Acuta Capital Fund, LP 400 1,0975 400 1,0975 439
2018-03-02 Acuta Capital Fund, LP 680 1,0800 680 1,0800 734
2018-03-01 Acuta Capital Fund, LP 1.814 1,0746 1.814 1,0746 1.949
2018-02-28 Acuta Capital Fund, LP 2.720 1,1498 2.720 1,1498 3.127
2018-02-23 Acuta Capital Fund, LP 333 1,1300 333 1,1300 376

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CASM / CAS Medical Systems, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CASM / CAS Medical Systems, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-08-09 Gamelin John 5.000 2,6700 5.000 2,6700 13.350 140 1.4600 -6.050 -45,32
2018-08-07 Gamelin John 5.000 2,5700 5.000 2,5700 12.850
2018-06-06 Gamelin John 5.000 1,7500 5.000 1,7500 8.750
2018-06-06 Gamelin John 5.000 1,7200 5.000 1,7200 8.600
2018-05-17 Gamelin John 5.000 1,6800 5.000 1,6800 8.400
2018-05-17 Gamelin John 5.000 1,6600 5.000 1,6600 8.300
2018-05-16 Gamelin John 1.000 1,3800 1.000 1,3800 1.380
2018-05-16 Gamelin John 1.000 1,4400 1.000 1,4400 1.440
2018-05-16 Gamelin John 1.000 1,4100 1.000 1,4100 1.410

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CASM / CAS Medical Systems, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Nominee II, LLC CASM Series A Exchangeable Preferred Stock C - Conversion I -561 0
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Associates II LP CASM Series A Exchangeable Preferred Stock C - Conversion I -191 0
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. CASM Series A Exchangeable Preferred Stock C - Conversion D -53.748 0
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Nominee II, LLC CASM Series A Convertible Preferred Stock C - Conversion I -984 0
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Associates II LP CASM Series A Convertible Preferred Stock C - Conversion I -334 0
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. CASM Series A Convertible Preferred Stock C - Conversion D -94.182 0
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Nominee II, LLC CASM Common Stock D - Sale to Issuer I 2,4500 -119.872 -294 0
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Associates II LP CASM Common Stock D - Sale to Issuer I 2,4500 -43.944 -108 0
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. CASM Common Stock D - Sale to Issuer D 2,4500 -12.300.186 -30.135 0
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Nominee II, LLC CASM Common Stock C - Conversion I 2,3890 40.772 97 119.872
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Associates II LP CASM Common Stock C - Conversion I 2,3890 13.881 33 43.944
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. CASM Common Stock C - Conversion D 2,3890 3.906.315 9.332 12.300.186
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Nominee II, LLC CASM Common Stock C - Conversion I 2,3890 71.075 170 79.100
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. by TMP Associates II LP CASM Common Stock C - Conversion I 2,3890 24.125 58 30.063
2019-04-22 2019-04-18 4 Thomas, McNerney & Partners II L.P. CASM Common Stock C - Conversion D 2,3890 6.802.834 16.252 8.393.871
2019-04-22 2019-04-18 4 PATTON THOMAS M CASM Stock Option D - Sale to Issuer D 0,67 -60.000 0
2019-04-22 2019-04-18 4 PATTON THOMAS M CASM Stock Option D - Sale to Issuer D 1,69 -100.000 0
2019-04-22 2019-04-18 4 PATTON THOMAS M CASM Stock Option D - Sale to Issuer D 1,79 -100.000 0
2019-04-22 2019-04-18 4 PATTON THOMAS M CASM Stock Option D - Sale to Issuer D 1,87 -100.000 0
2019-04-22 2019-04-18 4 PATTON THOMAS M CASM Stock Option D - Sale to Issuer D 2,18 -100.000 0
2019-04-22 2019-04-18 4 PATTON THOMAS M CASM Stock Option D - Sale to Issuer D 2,10 -350.000 0
2019-04-22 2019-04-18 4 PATTON THOMAS M CASM Common Stock D - Sale to Issuer D -150.000 0
2019-04-22 2019-04-18 4 PATTON THOMAS M CASM Common Stock D - Sale to Issuer D 2,4500 -930.889 -2.281 150.000
2019-04-22 2019-04-18 4 MILINAZZO ALAN CASM Stock Option D - Sale to Issuer D 1,64 -15.000 0
2019-04-22 2019-04-18 4 MILINAZZO ALAN CASM Stock Option D - Sale to Issuer D 1,26 -30.000 0
2019-04-22 2019-04-18 4 MILINAZZO ALAN CASM Common Stock D - Sale to Issuer D 2,4500 -42.500 -104 0
2019-04-22 2019-04-18 4 Molloy Paul A CASM Stock Option D - Sale to Issuer D 1,64 -15.000 0
2019-04-22 2019-04-18 4 Molloy Paul A CASM Stock Option D - Sale to Issuer D 1,68 -30.000 0
2019-04-22 2019-04-18 4 Molloy Paul A CASM Common Stock D - Sale to Issuer D 2,4500 -42.500 -104 0
2019-04-22 2019-04-18 4 Gamelin John CASM Stock Option D - Sale to Issuer D 0,67 -20.000 0
2019-04-22 2019-04-18 4 Gamelin John CASM Stock Option D - Sale to Issuer D 1,79 -40.000 0
2019-04-22 2019-04-18 4 Gamelin John CASM Stock Option D - Sale to Issuer D 1,87 -40.000 0
2019-04-22 2019-04-18 4 Gamelin John CASM Stock Option D - Sale to Issuer D 2,18 -60.000 0
2019-04-22 2019-04-18 4 Gamelin John CASM Stock Option D - Sale to Issuer D 1,69 -56.000 0
2019-04-22 2019-04-18 4 Gamelin John CASM Stock Option D - Sale to Issuer D 3,00 -44.000 0
2019-04-22 2019-04-18 4 Gamelin John CASM Common Stock D - Sale to Issuer D 2,4500 -186.078 -456 0
2019-04-22 2019-04-18 4 BAIRD JEFFERY A CASM Stock Option D - Sale to Issuer D 0,67 -20.000 0
2019-04-22 2019-04-18 4 BAIRD JEFFERY A CASM Stock Option D - Sale to Issuer D 2,18 -40.000 0
2019-04-22 2019-04-18 4 BAIRD JEFFERY A CASM Stock Option D - Sale to Issuer D 1,79 -40.000 0
2019-04-22 2019-04-18 4 BAIRD JEFFERY A CASM Stock Option D - Sale to Issuer D 1,87 -50.000 0
2019-04-22 2019-04-18 4 BAIRD JEFFERY A CASM Stock Option D - Sale to Issuer D 3,16 -50.000 0
2019-04-22 2019-04-18 4 BAIRD JEFFERY A CASM Stock Option D - Sale to Issuer D 1,69 -25.000 0
2019-04-22 2019-04-18 4 BAIRD JEFFERY A CASM Common Stock D - Sale to Issuer D 2,4500 -304.418 -746 0
2019-04-22 2019-04-18 4 Tune Kathleen A CASM Stock Option D - Sale to Issuer D 1,64 -15.000 0
2019-04-22 2019-04-18 4 Tune Kathleen A CASM Stock Option D - Sale to Issuer D 1,68 -30.000 0
2019-04-22 2019-04-18 4 Tune Kathleen A CASM Stock Option D - Sale to Issuer D 2,54 -20.000 0
2019-04-22 2019-04-18 4 Tune Kathleen A CASM Common Stock D - Sale to Issuer D 2,4500 -63.454 -155 0
2019-04-22 2019-04-18 4 THOMAS JAMES E CASM Stock Option D - Sale to Issuer D 1,68 -30.000 0
2019-04-22 2019-04-18 4 THOMAS JAMES E CASM Stock Option D - Sale to Issuer D 2,54 -20.000 0
2019-04-22 2019-04-18 4 THOMAS JAMES E CASM Common Stock D - Sale to Issuer D 2,4500 -63.454 -155 0
2019-04-22 2019-04-11 4 THOMAS JAMES E CASM Stock Option D - Sale to Issuer D 1,64 -15.000 0
2019-04-22 2019-04-18 4 WEISSHAAR KENNETH R CASM Stock Option D - Sale to Issuer D 1,64 -15.000 0
2019-04-22 2019-04-18 4 WEISSHAAR KENNETH R CASM Stock Option D - Sale to Issuer D 1,68 -30.000 0
2019-04-22 2019-04-18 4 WEISSHAAR KENNETH R CASM Stock Option D - Sale to Issuer D 1,90 -20.000 0
2019-04-22 2019-04-18 4 WEISSHAAR KENNETH R CASM Common Stock D - Sale to Issuer D 2,4500 -70.303 -172 0
2019-04-22 2019-04-18 4 Benni Paul CASM Stock Option D - Sale to Issuer D 0,67 -20.000 0
2019-04-22 2019-04-18 4 Benni Paul CASM Stock Option D - Sale to Issuer D 2,18 -25.000 0
2019-04-22 2019-04-18 4 Benni Paul CASM Stock Option D - Sale to Issuer D 1,79 -25.000 0
2019-04-22 2019-04-18 4 Benni Paul CASM Stock Option D - Sale to Issuer D 1,87 -25.000 0
2019-04-22 2019-04-18 4 Benni Paul CASM Stock Option D - Sale to Issuer D 1,69 -56.000 0
2019-04-22 2019-04-18 4 Benni Paul CASM Stock Option D - Sale to Issuer D 3,00 -44.000 0
2019-04-22 2019-04-18 4 Benni Paul CASM Common Stock D - Sale to Issuer D 2,4500 -177.379 -435 0
2019-04-22 2019-04-18 4 Rainey Gregory P CASM Stock Option D - Sale to Issuer D 1,64 -15.000 0
2019-04-22 2019-04-18 4 Rainey Gregory P CASM Stock Option D - Sale to Issuer D 1,68 -30.000 0
2019-04-22 2019-04-18 4 Rainey Gregory P CASM Stock Option D - Sale to Issuer D 2,95 -20.000 0
2019-04-22 2019-04-18 4 Rainey Gregory P CASM Common Stock D - Sale to Issuer D 2,4500 -70.431 -173 0
2019-04-18 2019-04-18 4 Edwards Lifesciences Holding, Inc. CASM Common Stock, $0.004 par value per share J - Other D 40.049.789 40.049.789
2019-02-21 3 Edwards Lifesciences Corp See Footnotes CASM Common Stock, $0.004 par value I 0
2019-02-21 3 Edwards Lifesciences Corp See Footnotes CASM Exchangeable Preferred Stock, $0.001 par value I 0
2019-02-21 3 Edwards Lifesciences Corp See Footnotes CASM Convertible Preferred Stock, $0.001 par value I 0
2018-12-21 2018-12-20 4 Gamelin John CASM Common Stock A - Award D 40.000 186.078
2018-12-21 2018-12-20 4 Benni Paul CASM Common Stock A - Award D 15.000 177.379
2018-12-21 2018-12-20 4 BAIRD JEFFERY A CASM Common Stock A - Award D 40.000 304.418
2018-12-21 2018-12-20 4 PATTON THOMAS M CASM Common Stock A - Award D 75.000 1.080.889
2018-12-17 2018-12-13 4 WEISSHAAR KENNETH R CASM Common Stock A - Award D 15.000 70.303
2018-12-17 2018-12-13 4 Tune Kathleen A CASM Common Stock A - Award D 15.000 63.454
2018-12-17 2018-12-13 4 Rainey Gregory P CASM Common Stock A - Award D 15.000 70.431
2018-12-17 2018-12-13 4 MILINAZZO ALAN CASM Common Stock A - Award D 15.000 42.500
2018-12-17 2018-12-13 4 Molloy Paul A CASM Common Stock A - Award D 15.000 42.500
2018-12-17 2018-12-13 4 THOMAS JAMES E CASM Common Stock A - Award D 15.000 63.454
2018-08-13 2018-08-09 4 Gamelin John CASM Common Stock S - Sale D 2,6700 -5.000 -13 146.078
2018-08-08 2018-08-07 4 Gamelin John CASM Common Stock S - Sale D 2,5700 -5.000 -13 151.078
2018-08-02 2018-08-01 4 PATTON THOMAS M CASM Common Stock A - Award D 25.000 1.005.889
2018-08-02 2018-08-01 4 PATTON THOMAS M CASM Common Stock A - Award D 25.000 1.005.889
2018-06-07 2018-06-06 4 Gamelin John CASM Common Stock S - Sale D 1,7500 -5.000 -9 156.078
2018-06-07 2018-06-06 4 Gamelin John CASM Common Stock S - Sale D 1,7200 -5.000 -9 161.078
2018-05-21 2018-05-17 4 Gamelin John CASM Common Stock S - Sale D 1,6800 -5.000 -8 166.078
2018-05-21 2018-05-17 4 Gamelin John CASM Common Stock S - Sale D 1,6600 -5.000 -8 171.078
2018-05-21 2018-05-16 4 Gamelin John CASM Common Stock S - Sale D 1,4400 -1.000 -1 176.078
2018-05-21 2018-05-16 4 Gamelin John CASM Common Stock S - Sale D 1,4100 -1.000 -1 177.078
2018-05-18 2018-05-17 4 PATTON THOMAS M Relative's IRA CASM Common Stock J - Other I -32.500 0
2018-05-16 2018-05-16 4 Gamelin John CASM Common Stock S - Sale D 1,3800 -1.000 -1 178.078
2018-05-16 2018-05-14 4 Gamelin John CASM Common Stock S - Sale D 1,3500 -1.000 -1 179.078
2018-05-16 2018-05-14 4 Gamelin John CASM Common Stock S - Sale D 1,3700 -1.000 -1 180.078
2018-05-01 3 Acuta Capital Fund, LP CASM Common Stock D 5.501.098
2018-05-01 3 Acuta Capital Fund, LP CASM Common Stock D 5.501.098
2018-05-01 3 Acuta Capital Fund, LP CASM Common Stock D 5.501.098
2018-05-01 2017-03-07 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4478 4.020 6 2.901.777
2018-05-01 2017-03-01 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4800 23.306 34 2.897.757
2018-05-01 2017-02-28 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4891 1.639 2 2.874.451
2018-05-01 2017-02-27 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4958 2.010 3 2.872.812
2018-05-01 2017-02-24 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4900 1.340 2 2.870.802
2018-05-01 2017-02-23 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4650 2.680 4 2.869.462
2018-05-01 2017-02-22 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4933 4.020 6 2.866.782
2018-05-01 2017-02-21 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4950 670 1 2.862.762
2018-05-01 2017-02-15 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5095 1.340 2 2.862.092
2018-05-01 2017-02-13 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5000 670 1 2.860.752
2018-05-01 2017-02-10 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4995 1.675 3 2.860.082
2018-05-01 2017-02-08 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5250 895 1 2.858.407
2018-05-01 2017-02-07 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5127 2.010 3 2.857.512
2018-05-01 2017-02-06 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5300 670 1 2.855.502
2018-05-01 2017-02-03 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5311 15.798 24 2.854.832
2018-05-01 2017-02-02 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5507 1.876 3 2.839.034
2018-05-01 2017-01-31 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5241 1.452 2 2.837.158
2018-05-01 2017-01-30 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5146 2.706 4 2.835.706
2018-05-01 2017-01-27 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5124 2.640 4 2.833.000
2018-05-01 2017-01-20 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5473 5.676 9 2.830.360
2018-05-01 2017-01-19 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5998 38.940 62 2.824.684
2018-05-01 2017-01-18 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,6864 10.829 18 2.785.744
2018-05-01 2017-01-17 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,7186 1.015 2 2.774.915
2018-05-01 2017-01-13 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,7150 3.170 5 2.773.900
2018-05-01 2017-01-11 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,6528 8.118 13 2.770.730
2018-05-01 2017-01-10 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,6149 3.360 5 2.762.612
2018-05-01 2017-01-09 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,6322 3.366 5 2.759.252
2018-05-01 2017-01-06 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,6151 4.068 7 2.755.886
2018-05-01 2017-01-05 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,6081 411 1 2.751.818
2018-05-01 2017-01-04 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5950 858 1 2.751.407
2018-05-01 2017-07-24 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1695 8.690 10 3.238.458
2018-05-01 2017-07-21 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1631 3.625 4 3.229.768
2018-05-01 2017-07-19 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1641 7.900 9 3.226.143
2018-05-01 2017-07-18 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1619 5.685 7 3.218.243
2018-05-01 2017-07-17 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1814 5.530 7 3.212.558
2018-05-01 2017-07-14 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1899 8.690 10 3.207.028
2018-05-01 2017-07-13 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1560 3.485 4 3.198.338
2018-05-01 2017-07-12 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1910 6.320 8 3.194.853
2018-05-01 2017-07-11 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1967 10.270 12 3.188.533
2018-05-01 2017-07-10 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1950 3.160 4 3.178.263
2018-05-01 2017-07-07 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1796 4.216 5 3.175.103
2018-05-01 2017-07-06 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1697 7.916 9 3.170.887
2018-05-01 2017-07-05 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1800 111 0 3.162.971
2018-05-01 2017-07-03 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1667 1.335 2 3.162.860
2018-05-01 2017-06-30 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1486 21.250 24 3.161.525
2018-05-01 2017-06-29 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1770 25.519 30 3.140.275
2018-05-01 2017-06-28 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1780 17.643 21 3.114.756
2018-05-01 2017-06-27 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1731 7.595 9 3.097.113
2018-05-01 2017-06-26 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1389 28.476 32 3.089.518
2018-05-01 2017-06-23 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1397 21.142 24 3.061.042
2018-05-01 2017-06-22 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,0944 25.551 28 3.039.900
2018-05-01 2017-06-21 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,0420 41.540 43 3.014.349
2018-05-01 2017-06-20 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,0076 37.520 38 2.972.809
2018-05-01 2017-03-17 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4969 16.853 25 2.935.289
2018-05-01 2017-03-16 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4866 2.010 3 2.918.436
2018-05-01 2017-03-15 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5232 1.632 2 2.916.426
2018-05-01 2017-03-13 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4664 3.292 5 2.914.764
2018-05-01 2017-03-10 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,5008 895 1 2.911.502
2018-05-01 2017-03-09 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4840 7.490 11 2.910.607
2018-05-01 2017-03-08 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,4445 1.340 2 2.903.117
2018-05-01 2017-12-26 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,7161 9.660 7 3.428.683
2018-05-01 2017-12-19 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,6481 7.476 5 3.419.023
2018-05-01 2017-12-18 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,6559 2.760 2 3.411.547
2018-05-01 2017-12-15 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,6380 3.450 2 3.408.787
2018-05-01 2017-12-14 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,6263 5.520 3 3.405.337
2018-05-01 2017-12-13 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,6207 2.070 1 3.399.817
2018-05-01 2017-09-08 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9000 222 0 3.397.747
2018-05-01 2017-09-07 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,8857 2.464 2 3.397.525
2018-05-01 2017-08-29 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9279 1.088 1 3.395.061
2018-05-01 2017-08-24 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9525 2.720 3 3.393.973
2018-05-01 2017-08-23 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9595 5.576 5 3.391.253
2018-05-01 2017-08-22 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9850 816 1 3.385.677
2018-05-01 2017-08-18 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9909 1.565 2 3.384.861
2018-05-01 2017-08-17 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9648 4.284 4 3.383.296
2018-05-01 2017-08-16 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9900 333 0 3.379.012
2018-05-01 2017-08-15 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9649 2.720 3 3.378.679
2018-05-01 2017-08-11 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,0018 5.440 5 3.375.959
2018-05-01 2017-08-10 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9823 8.656 9 3.370.519
2018-05-01 2017-08-09 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9917 4.080 4 3.361.863
2018-05-01 2017-08-08 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,9856 26.384 26 3.357.783
2018-05-01 2017-08-07 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1813 2.311 3 3.331.399
2018-05-01 2017-08-04 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1789 2.624 3 3.329.088
2018-05-01 2017-08-03 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1710 4.051 5 3.326.464
2018-05-01 2017-08-02 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1753 1.292 2 3.322.413
2018-05-01 2017-08-01 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1800 3.400 4 3.321.121
2018-05-01 2017-07-31 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1850 1.340 2 3.317.721
2018-05-01 2017-07-28 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1876 10.287 12 3.316.381
2018-05-01 2017-07-27 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1838 2.088 2 3.306.094
2018-05-01 2017-07-26 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1971 59.228 71 3.304.006
2018-05-01 2017-07-25 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1770 6.320 7 3.244.778
2018-05-01 2018-03-19 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,2513 1.088 1 3.483.146
2018-05-01 2018-03-16 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,2500 2.176 3 3.482.058
2018-05-01 2018-03-15 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1583 9.370 11 3.479.882
2018-05-01 2018-03-09 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,0723 1.180 1 3.470.512
2018-05-01 2018-03-08 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,0975 400 0 3.469.332
2018-05-01 2018-03-02 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,0800 680 1 3.468.932
2018-05-01 2018-03-01 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,0746 1.814 2 3.468.252
2018-05-01 2018-02-28 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1498 2.720 3 3.466.438
2018-05-01 2018-02-23 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1300 333 0 3.463.718
2018-05-01 2018-02-21 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1000 300 0 3.463.385
2018-05-01 2018-02-20 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1128 2.290 3 3.463.085
2018-05-01 2018-02-16 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1692 832 1 3.460.795
2018-05-01 2018-02-13 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1830 975 1 3.459.963
2018-05-01 2018-02-12 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1462 884 1 3.458.988
2018-05-01 2018-02-09 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1540 4.964 6 3.458.104
2018-05-01 2018-02-06 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1718 2.811 3 3.453.140
2018-05-01 2018-02-02 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,1900 1.000 1 3.450.329
2018-05-01 2018-01-17 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 1,0500 100 0 3.449.329
2018-05-01 2018-01-04 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,8570 5.440 5 3.449.229
2018-05-01 2017-12-29 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,7390 8.896 7 3.443.789
2018-05-01 2017-12-28 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,6996 1.380 1 3.434.893
2018-05-01 2017-12-27 4 Acuta Capital Fund, LP CASM Common Stock P - Purchase D 0,7196 4.830 3 3.433.513
2018-04-02 2018-03-15 4 Gamelin John CASM Common Stock S - Sale D 1,1800 -500 -1 181.078
2018-04-02 2018-03-15 4 Gamelin John CASM Common Stock S - Sale D 1,1500 -800 -1 181.578
2018-04-02 2018-03-15 4 Gamelin John CASM Common Stock S - Sale D 1,1626 -1.200 -1 182.378
2018-04-02 2018-03-15 4 Gamelin John CASM Common Stock S - Sale D 1,1685 -500 -1 183.578
2018-03-08 2018-03-06 4 Gamelin John CASM Common Stock A - Award D 13.321 184.078
2018-03-08 2018-03-06 4 Benni Paul CASM Common Stock A - Award D 16.832 162.379
2018-03-08 2018-03-06 4 BAIRD JEFFERY A CASM Common Stock A - Award D 14.684 264.418
2018-01-02 2017-12-21 4/A PATTON THOMAS M CASM Stock Option A - Award D 0,67 60.000 60.000
2018-01-02 2017-12-21 4/A PATTON THOMAS M CASM Common Stock A - Award D 40.000 955.889
2017-12-26 2017-12-21 4 MILINAZZO ALAN CASM Common Stock A - Award D 15.000 27.500
2017-12-26 2017-12-21 4 Benni Paul CASM Stock Option A - Award D 0,67 20.000 20.000
2017-12-26 2017-12-21 4 Benni Paul CASM Common Stock A - Award D 10.000 145.547
2017-12-26 2017-12-21 4 THOMAS JAMES E CASM Common Stock A - Award D 15.000 48.454
2017-12-26 2017-12-21 4 Molloy Paul A CASM Common Stock A - Award D 15.000 27.500
2017-12-26 2017-12-21 4 PATTON THOMAS M CASM Stock Option A - Award D 0,67 60.000 60.000
2017-12-26 2017-12-21 4 PATTON THOMAS M CASM Common Stock A - Award D 70.000 985.889
2017-12-26 2017-12-21 4 Gamelin John CASM Stock Option A - Award D 0,67 20.000 20.000
2017-12-26 2017-12-21 4 Gamelin John CASM Common Stock A - Award D 35.000 170.757
2017-12-26 2017-12-21 4 WEISSHAAR KENNETH R CASM Common Stock A - Award D 15.000 55.303
2017-12-26 2017-12-21 4 Tune Kathleen A CASM Common Stock A - Award D 15.000 48.454
2017-12-26 2017-12-21 4 BAIRD JEFFERY A CASM Stock Option A - Award D 0,67 20.000 20.000
2017-12-26 2017-12-21 4 BAIRD JEFFERY A CASM Common Stock A - Award D 35.000 249.734
2017-12-26 2017-12-21 4 Rainey Gregory P CASM Common Stock A - Award D 15.000 55.431
2017-03-14 2017-03-10 4 PATTON THOMAS M CASM Common Stock A - Award D 74.212 915.889
2017-03-14 2017-03-10 4 BAIRD JEFFERY A CASM Common Stock A - Award D 33.945 214.734
2017-03-14 2017-03-10 4 Benni Paul CASM Common Stock A - Award D 19.476 135.547
2017-03-14 2017-03-10 4 Gamelin John CASM Common Stock A - Award D 30.757 135.757
2017-01-26 2017-01-26 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CASM Common Stock S - Sale I 1,4551 -517.450 -753 2.358.636
2017-01-26 2017-01-25 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CASM Common Stock S - Sale I 1,5003 -71.468 -107 2.876.086
2017-01-26 2017-01-24 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CASM Common Stock S - Sale I 1,5018 -47.320 -71 2.947.554
2017-01-23 2017-01-23 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CASM Common Stock S - Sale I 1,4650 -86.691 -127 2.994.874
2017-01-23 2017-01-20 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CASM Common Stock S - Sale I 1,5319 -46.522 -71 3.081.565
2017-01-23 2017-01-19 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CASM Common Stock S - Sale I 1,6003 -71.913 -115 3.128.087
2017-01-11 2017-01-09 4 Tune Kathleen A CASM Common Stock A - Award D 12.500 33.454
2017-01-11 2017-01-09 4 MILINAZZO ALAN CASM Common Stock A - Award D 12.500 12.500
2017-01-11 2017-01-09 4 Rainey Gregory P CASM Common Stock A - Award D 12.500 40.431
2017-01-11 2017-01-09 4 Molloy Paul A CASM Common Stock A - Award D 12.500 12.500
2017-01-11 2017-01-09 4 PATTON THOMAS M CASM Common Stock A - Award D 100.000 841.677
2017-01-11 2017-01-09 4 BAIRD JEFFERY A CASM Common Stock A - Award D 45.000 180.789
2017-01-11 2017-01-09 4 Gamelin John CASM Common Stock A - Award D 45.000 105.000
2017-01-11 2017-01-09 4 Benni Paul CASM Common Stock A - Award D 20.000 116.071
2017-01-11 2017-01-09 4 THOMAS JAMES E CASM Common Stock A - Award D 12.500 33.454
2017-01-11 2017-01-09 4 WEISSHAAR KENNETH R CASM Common Stock A - Award D 12.500 40.303
2016-01-22 2015-12-17 4/A Benni Paul CASM Common Stock A - Award D 22.500 96.071
2015-12-21 2015-12-17 4 Benni Paul CASM Common Stock A - Award D 22.500 96.251
2015-12-21 2015-12-17 4 Gamelin John CASM Common Stock A - Award D 60.000 60.000
2015-12-21 2015-12-17 4 Tune Kathleen A CASM Stock Options A - Award D 1,64 15.000 15.000
2015-12-21 2015-12-17 4 Molloy Paul A CASM Stock Options A - Award D 1,64 15.000 15.000
2015-12-21 2015-12-17 4 PATTON THOMAS M CASM Common Stock A - Award D 150.000 741.677
2015-12-21 2015-12-17 4 BAIRD JEFFERY A CASM Common Stock A - Award D 60.000 135.789
2015-12-21 2015-12-17 4 WEISSHAAR KENNETH R CASM Stock Options A - Award D 1,64 15.000 15.000
2015-12-21 2015-12-17 4 Rainey Gregory P CASM Stock Options A - Award D 1,64 15.000 15.000
2015-12-21 2015-12-17 4 MILINAZZO ALAN CASM Stock Options A - Award D 1,64 15.000 15.000
2015-12-21 2015-12-17 4 THOMAS JAMES E CASM Stock Options A - Award D 1,64 15.000 15.000
2015-06-25 3 MILINAZZO ALAN CASM Common Stock D 0
2015-06-25 2015-06-23 4 MILINAZZO ALAN CASM Stock Option A - Award D 1,26 30.000 30.000
2015-05-28 2015-05-28 4 Wagner Brian J CASM Common Stock P - Purchase D 1,2500 500 1 5.400
2015-05-18 2015-05-15 4 Wagner Brian J CASM Common Stock P - Purchase D 1,3100 1.932 3 4.900
2015-05-18 2015-05-14 4 Wagner Brian J CASM Common Stock P - Purchase D 1,2300 100 0 2.968
2015-03-31 2015-01-05 4/A Tune Kathleen A CASM Stock Option A - Award D 1,68 30.000 30.000
2015-03-31 2015-01-05 4/A WEISSHAAR KENNETH R CASM Common Stock A - Award D 1,68 30.000 30.000
2015-03-31 2015-01-05 4/A Rainey Gregory P CASM Stock Option A - Award D 1,68 30.000 30.000
2015-03-31 2015-01-05 4/A THOMAS JAMES E CASM Stock Option A - Award D 1,68 30.000 30.000
2015-02-13 2015-02-11 4 PATTON THOMAS M CASM Common Stock P - Purchase D 1,3000 40.000 52 591.677
2015-02-13 2015-02-11 4 Thomas, McNerney & Partners II L.P. by TMP Associates II, LP CASM Common Stock P - Purchase I 1,3000 5.938 8 5.938
2015-02-13 2015-02-11 4 Thomas, McNerney & Partners II L.P. by TMP Nominee II, LLC CASM Common Stock P - Purchase I 1,3000 8.025 10 8.025
2015-02-13 2015-02-11 4 Thomas, McNerney & Partners II L.P. CASM Common Stock P - Purchase D 1,3000 1.591.037 2.068 1.632.945
2015-02-13 2015-02-11 4 THOMAS JAMES E by TMP Associates II, LP CASM Common Stock P - Purchase I 1,3000 5.938 8 5.938
2015-02-13 2015-02-11 4 THOMAS JAMES E by TMP Nominee II, LLC CASM Common Stock P - Purchase I 1,3000 8.025 10 8.025
2015-02-13 2015-02-11 4 THOMAS JAMES E by Thomas, McNerney & Partners II, L.P. CASM Common Stock P - Purchase I 1,3000 1.591.037 2.068 1.591.037
2015-01-07 3 Molloy Paul A CASM Common Stock D 0
2015-01-07 2015-01-05 4 Rainey Gregory P CASM Stock Option A - Award D 1,68 30.000 30.000
2015-01-07 2015-01-05 4 WEISSHAAR KENNETH R CASM Stock Option A - Award D 1,68 30.000 30.000
2015-01-07 2015-01-05 4 THOMAS JAMES E CASM Stock Option A - Award D 1,68 30.000 30.000
2015-01-07 2015-01-05 4 Molloy Paul A CASM Stock Option A - Award D 1,68 30.000 30.000
2015-01-07 2015-01-05 4 Tune Kathleen A CASM Stock Option A - Award D 1,68 30.000 30.000
2015-01-05 2015-01-01 4 Flynn James E Through Deerfield Special Situations International Master Fund, L.P. CASM Common Stock S - Sale I 1,6500 -1.443.200 -2.381 0
2015-01-05 2015-01-01 4 Flynn James E Through Deerfield Special Situations, L.P. CASM Common Stock P - Purchase I 1,6500 1.443.200 2.381 3.200.000
2014-12-22 2014-12-18 4 PATTON THOMAS M CASM Stock Option A - Award D 1,79 100.000 100.000
2014-12-22 2014-12-18 4 BAIRD JEFFERY A CASM Stock Option A - Award D 1,79 40.000 40.000
2014-12-22 2014-12-18 4 Benni Paul CASM Stock Option A - Award D 1,79 25.000 25.000
2014-12-22 2014-12-18 4 Gamelin John CASM Stock Option A - Award D 1,79 40.000 40.000
2014-12-22 2014-12-18 4 Wagner Brian J CASM Stock Option A - Award D 1,79 40.000 40.000
2014-09-03 2014-09-02 4 PATTON THOMAS M CASM Common Stock P - Purchase D 1,4800 1.500 2 551.677
2014-08-19 2014-08-18 4 PATTON THOMAS M CASM Common Stock P - Purchase D 1,5410 10.000 15 550.177
2014-08-11 2014-08-08 4 PATTON THOMAS M CASM Common Stock P - Purchase D 1,6053 10.000 16 540.177
2014-06-27 2014-06-25 4 WEISSHAAR KENNETH R CASM Common Stock A - Award D 5.076 27.803
2014-06-27 2014-06-25 4 Rainey Gregory P CASM Common Stock A - Award D 5.076 27.931
2014-06-26 2014-06-25 4 Tune Kathleen A CASM Common Stock A - Award D 5.076 20.954
2014-06-26 2014-06-25 4 BURSTEIN LAWRENCE CASM Common Stock A - Award D 5.076 39.685
2014-06-26 2014-06-25 4 THOMAS JAMES E CASM Common Stock A - Award D 5.076 20.954
2014-01-31 2014-01-30 4 BAIRD JEFFERY A CASM Common Stock A - Award D 15.000 75.789
2013-12-18 2013-12-16 4 BAIRD JEFFERY A CASM Stock Option A - Award D 1,87 50.000 50.000
2013-12-18 2013-12-16 4 Benni Paul CASM Stock Option A - Award D 1,87 25.000 25.000
2013-12-18 2013-12-16 4 PATTON THOMAS M CASM Stock Option A - Award D 1,87 100.000 100.000
2013-12-18 2013-12-16 4 Gamelin John CASM Stock Option A - Award D 1,87 40.000 40.000
2013-10-03 3 Wagner Brian J CASM Common Stock D 0
2013-10-03 2013-10-02 4 Wagner Brian J CASM Option (Right to Buy) A - Award D 1,35 250.000 250.000
2013-08-22 2013-08-21 4 PATTON THOMAS M CASM Common Stock P - Purchase D 1,4200 5.300 8 530.177
2013-07-17 3 Deerfield Special Situations International Master Fund, L.P. Through Deerfield Special Situations International Master Fund, L.P. CASM Common Stock I 1.443.200
2013-07-17 3 Deerfield Special Situations International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. CASM Common Stock I 1.756.800
2013-07-03 2013-06-24 4 Rainey Gregory P CASM Common Stock A - Award D 6.211 22.855
2013-07-02 2013-06-24 4 JONES EVAN/ FA CASM Common Stock A - Award D 6.211 44.768
2013-07-02 2013-06-24 4 BURSTEIN LAWRENCE CASM Common Stock A - Award D 6.211 34.609
2013-07-02 2013-06-24 4 WEISSHAAR KENNETH R CASM Common Stock A - Award D 6.211 22.727
2013-07-02 2013-06-24 4 Tune Kathleen A CASM Common Stock A - Award D 6.211 15.878
2013-07-02 2013-06-24 4 THOMAS JAMES E CASM Common Stock A - Award D 6.211 15.878
2013-04-22 3 Benni Paul CASM Common Stock D 73.571
2013-02-25 2013-02-21 4 PATTON THOMAS M CASM Common Stock A - Award D 11.000 524.877
2012-12-19 2012-12-17 4 PATTON THOMAS M CASM Stock Option A - Award D 2,18 100.000 100.000
2012-12-19 2012-12-17 4 Herwig Matthew J CASM Stock Option A - Award D 2,18 40.000 40.000
2012-12-19 2012-12-17 4 Gamelin John CASM Stock Option A - Award D 2,18 60.000 60.000
2012-12-19 2012-12-17 4 BAIRD JEFFERY A CASM Stock Option A - Award D 2,18 40.000 40.000
2012-12-04 3 Gamelin John CASM Common Stock D 0
2012-09-07 2012-09-06 4 PATTON THOMAS M CASM Common Stock P - Purchase D 1,9000 8.770 17 513.877
2012-09-07 2012-09-05 4 PATTON THOMAS M CASM Common Stock P - Purchase D 1,8000 1.562 3 505.107
2012-06-22 2012-06-20 4 Tune Kathleen A CASM Common Stock A - Award D 5.714 9.667
2012-06-22 2012-06-20 4 BURSTEIN LAWRENCE CASM Common Stock A - Award D 5.714 28.398
2012-06-22 2012-06-20 4 WEISSHAAR KENNETH R CASM Common Stock A - Award D 5.714 16.516
2012-06-22 2012-06-20 4 Rainey Gregory P CASM Common Stock A - Award D 5.714 16.644
2012-06-22 2012-06-20 4 JONES EVAN/ FA CASM Common Stock A - Award D 5.714 38.557
2012-06-22 2012-06-20 4 THOMAS JAMES E CASM Common Stock A - Award D 5.714 9.667
2012-02-13 2011-11-21 4/A PATTON THOMAS M CASM Common Stock P - Purchase D 1,7490 10.526 18 503.545
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista